Login / Signup

Targeted temperature management at 36°C is a risk factor for ventilator-associated pneumonia.

Masaru NasunoYukari YokoyamaMitsuo MotobayashiKeiko KobayashiNorio OmoriTakemi MuraiNoriko KubotaMasatomo KitamuraKisei MinamiYuji Inaba
Published in: Pediatrics international : official journal of the Japan Pediatric Society (2023)
TTM at 36°C and mPSL pulse therapy may be risk factors for VAP in the pediatric population.
Keyphrases
  • blood pressure
  • cancer therapy
  • stem cells
  • drug delivery
  • intensive care unit
  • respiratory failure
  • bone marrow
  • extracorporeal membrane oxygenation
  • acute respiratory distress syndrome